Developing an international network for Alzheimer’s research: the Dominantly Inherited Alzheimer Network
Clinical Investigation2012Vol. 2(10), pp. 975–984
Citations Over TimeTop 10% of 2012 papers
John C. Morris, Paul Aisen, Randall J. Bateman, Tammie L.S. Benzinger, Nigel J. Cairns, Anne M. Fagan, Bernardino Ghetti, Alison Goate, David M. Holtzman, William E. Klunk, Eric McDade, Daniel S. Marcus, Ralph N. Martins, Colin L. Masters, Richard Mayeux, Angela Oliver, Kimberly A. Quaid, John M. Ringman, Martin N. Rossor, Stephen Salloway, Peter R. Schofield, Natalie J. Selsor, Reisa A. Sperling, Michael W. Weiner, Chengjie Xiong, Krista L. Moulder, Virginia Buckles
Abstract
The Dominantly Inherited Alzheimer Network (DIAN) is a collaborative effort of international Alzheimer disease (AD) centers that are conducting a multifaceted prospective biomarker study in individuals at-risk for autosomal dominant AD (ADAD). DIAN collects comprehensive information and tissue in accordance with standard protocols from asymptomatic and symptomatic ADAD mutation carriers and their non-carrier family members to determine the pathochronology of clinical, cognitive, neuroimaging, and fluid biomarkers of AD. This article describes the structure, implementation, and underlying principles of DIAN, as well as the demographic features of the initial DIAN cohort.
Related Papers
- → The assessment of transmission efficiency and latent infection period in asymptomatic carriers of SARS-CoV-2 infection(2020)50 cited
- → Identification and management of asymptomatic carriers of coronavirus disease 2019 (COVID‐19) in China(2020)7 cited
- → A considerable proportion of individuals with asymptomatic SARS-CoV-2 infection in Tibetan population(2020)22 cited
- → The clinical feature and follow up of asymptomatic coronavirus disease 2019 carriers: A study from Middle China(2020)
- → Clinical Features and Follow-Up of SARS-Cov-2 Asymptomatic Carriers(2020)